Experto en perfiles de medios
Enfermedades infecciosas
Harris Goldstein, MD
- Vicedecano de Asuntos Científicos del Hospital Infantil de Montefiore
- Profesor de Pediatría, Facultad de Medicina Albert Einstein
- Profesor, Departamento de Pediatría (Alergia e Inmunología Pediátrica)
- Professor, Department of Microbiology & Immunology
- Vicedecano sénior de Asuntos Científicos
- Cátedra Charles Michael en Enfermedades Autoinmunes
- Director del Centro Einstein-Rockefeller-CUNY-Mount Sinai para la Investigación del SIDA
Área de especialización
Ver perfil del profesoradoResumen del experto
Dr. Goldstein’s NIH-funded research centers on developing agents to amplify the capacity of the immune system to control HIV infection and achieve a functional cure for the disease. In seeking to “weaponize” the immune system to cure HIV, his lab uses molecular, cellular, and biochemical approaches, including CAR-T cells and the novel treatment strategy developed by Dr. Almo at Einstein for selective T cell amplification called synTac (synthetic T-cell activation).
Dr. Goldstein also studies the effects of HIV on the brain and central nervous system and the role of illicit drug use in accelerating HIV infection and causing neurological dysfunction. He is using mouse models developed in his lab to evaluate HIV vaccine candidates and other therapeutics.
As director of the NIH-funded Einstein-Rockefeller-CUNY Center for AIDS Research, Dr. Goldstein coordinates collaborations by more than 150 investigators from the three institutions. They are working to prevent HIV, to improve health outcomes for people living with HIV, and to find a cure for the HIV infection. In his role as associate dean of scientific resources at Einstein, he assesses new technologies for Einstein’s labs and oversees the work of over 40 shared scientific facilities.
